Reporter brief
Fisetin versus placebo for knee osteoarthritis pain in 3-month RCT (results not reported)
What happened
This was a double-blind randomized controlled trial of 60 patients with mild to moderate knee osteoarthritis, comparing two different fisetin dosing regimens against placebo over 3 months. The trial aimed to assess whether fisetin reduced pain and functional impairment, and evaluated changes in senescent cell activity and cartilage degradation biomarkers. No results are reported in this abstract.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Patients with mild to moderate knee osteoarthritis
- Design
- Rct
- Sample
- 60
- Journal
- Austin V Stone
- Published
- Jul 29, 2022
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Senolytics timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.